Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Times Interest Earned (2020 - 2025)

Historic Times Interest Earned for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to -$18.61.

  • Cytek Biosciences' Times Interest Earned rose 4787.51% to -$18.61 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.72, marking a year-over-year increase of 13091.28%. This contributed to the annual value of $3.92 for FY2024, which is 12913.57% up from last year.
  • As of Q3 2025, Cytek Biosciences' Times Interest Earned stood at -$18.61, which was up 4787.51% from -$25.66 recorded in Q2 2025.
  • Cytek Biosciences' Times Interest Earned's 5-year high stood at $8.8 during Q2 2021, with a 5-year trough of -$63.63 in Q2 2024.
  • For the 5-year period, Cytek Biosciences' Times Interest Earned averaged around -$13.34, with its median value being -$3.99 (2022).
  • As far as peak fluctuations go, Cytek Biosciences' Times Interest Earned surged by 10403.73% in 2021, and later plummeted by 152043.39% in 2023.
  • Quarter analysis of 5 years shows Cytek Biosciences' Times Interest Earned stood at $2.68 in 2021, then crashed by 95.43% to $0.12 in 2022, then tumbled by 384.38% to -$0.35 in 2023, then plummeted by 44.74% to -$0.5 in 2024, then crashed by 3597.15% to -$18.61 in 2025.
  • Its Times Interest Earned stands at -$18.61 for Q3 2025, versus -$25.66 for Q2 2025 and -$51.46 for Q1 2025.